Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial.

Publisher: American Public Health Association Country of Publication: United States NLM ID: 1254074 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1541-0048 (Electronic) Linking ISSN: 00900036 NLM ISO Abbreviation: Am J Public Health Subsets: MEDLINE

Publication: Washington, DC : American Public Health Association
Original Publication: New York [etc.]

Colorectal Neoplasms/*diagnosis ; Delivery of Health Care, Integrated/*methods ; Early Detection of Cancer/*statistics & numerical data ; Health Promotion/*methods ; Influenza, Human/*prevention & control; Aged ; California ; Colorectal Neoplasms/prevention & control ; Early Detection of Cancer/methods ; Female ; Humans ; Influenza Vaccines/administration & dosage ; Logistic Models ; Male ; Middle Aged ; Occult Blood ; Program Evaluation

Objectives: We tested the effectiveness of offering home fecal immunochemical tests (FITs) during influenza vaccination clinics to increase colorectal cancer screening (CRCS).
Methods: In a clinical trial at Kaiser Permanente Northern California influenza clinics in Redwood City, Richmond, South San Francisco, Union City, and Fresno, we randomly assigned influenza clinic dates to intervention (FIT offered) or control (FIT not offered) and compared subsequent CRCS activity.
Results: Clinic staff provided FITs to 53.9% (1805/3351) of intervention patients aged 50 to 75 years. In the intent-to-treat analysis, 26.9% (900/3351) and 11.7% (336/2884) of intervention and control patients completed an FIT, respectively, within 90 days of vaccination (P ≤ .001). The adjusted odds ratio for completing FIT in the intervention versus the control arm was 2.75 (95% confidence interval = 2.40, 3.16). In the per protocol analysis, 35.4% (648/1830) of patients given FIT and 13.3% (588/4405) of patients not given FIT completed FIT within 90 days of vaccination (P ≤ .001).
Conclusions: This intervention may increase CRCS among those not reached by other forms of CRCS outreach. Future research should include the extent to which these programs can be disseminated and implemented nationally.

Epidemiol Rev. 2011;33:101-10. (PMID: 21709143)
Ann Fam Med. 2009 Jan-Feb;7(1):17-23. (PMID: 19139445)
Ann Intern Med. 2008 Nov 4;149(9):627-37. (PMID: 18838716)
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. (PMID: 22237781)
Eval Health Prof. 2006 Mar;29(1):126-53. (PMID: 16510882)
J Health Care Poor Underserved. 2011 Feb;22(1):284-95. (PMID: 21317522)
MMWR Morb Mortal Wkly Rep. 2012 Jan 27;61(3):41-5. (PMID: 22278157)
Ann Intern Med. 2008 Nov 4;149(9):638-58. (PMID: 18838718)
Am J Gastroenterol. 2012 Jan;107(1):108-10. (PMID: 22218032)
Am J Prev Med. 2011 Jul;41(1):9-16. (PMID: 21665058)
Am J Manag Care. 2011;17(8):577-83. (PMID: 21851145)
Ann Behav Med. 2006 Apr;31(2):105-8. (PMID: 16542124)
Ann Intern Med. 2010 May 18;152(10):668-76. (PMID: 20388703)
J Natl Cancer Inst Monogr. 2010;2010(40):58-71. (PMID: 20386054)

UL1 RR02413 United States RR NCRR NIH HHS

0 (Influenza Vaccines)

Date Created: 20130420 Date Completed: 20130709 Latest Revision: 20211021

20231215

PMC3670663

10.2105/AJPH.2012.300998

23597357